Apyx Medical Corp
NASDAQ:APYX
Intrinsic Value
Apyx Medical Corp. operates as an energy-based medical technology company. [ Read More ]
The intrinsic value of one APYX stock under the Base Case scenario is 6.02 USD. Compared to the current market price of 1.38 USD, Apyx Medical Corp is Undervalued by 77%.
Valuation Backtest
Apyx Medical Corp
Run backtest to discover the historical profit from buying and selling APYX stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Apyx Medical Corp
Current Assets | 70.4m |
Cash & Short-Term Investments | 43.7m |
Receivables | 14.1m |
Other Current Assets | 12.7m |
Non-Current Assets | 8.9m |
PP&E | 7.1m |
Other Non-Current Assets | 1.7m |
Current Liabilities | 12.7m |
Accounts Payable | 2.7m |
Accrued Liabilities | 9.5m |
Other Current Liabilities | 508k |
Non-Current Liabilities | 39.8m |
Long-Term Debt | 33.2m |
Other Non-Current Liabilities | 6.6m |
Earnings Waterfall
Apyx Medical Corp
Revenue
|
52.3m
USD
|
Cost of Revenue
|
-18.6m
USD
|
Gross Profit
|
33.8m
USD
|
Operating Expenses
|
-53.7m
USD
|
Operating Income
|
-20m
USD
|
Other Expenses
|
1.2m
USD
|
Net Income
|
-18.7m
USD
|
Free Cash Flow Analysis
Apyx Medical Corp
What is Free Cash Flow?
APYX Profitability Score
Profitability Due Diligence
Apyx Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
Score
Apyx Medical Corp's profitability score is 26/100. The higher the profitability score, the more profitable the company is.
APYX Solvency Score
Solvency Due Diligence
Apyx Medical Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Score
Apyx Medical Corp's solvency score is 38/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
APYX Price Targets Summary
Apyx Medical Corp
According to Wall Street analysts, the average 1-year price target for APYX is 3.7 USD with a low forecast of 2.02 USD and a high forecast of 8.4 USD.
Ownership
APYX Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
APYX Price
Apyx Medical Corp
Average Annual Return | 27.43% |
Standard Deviation of Annual Returns | 93.48% |
Max Drawdown | -93% |
Market Capitalization | 47.8m USD |
Shares Outstanding | 34 643 900 |
Percentage of Shares Shorted | 2.12% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Apyx Medical Corp. operates as an energy-based medical technology company. The company is headquartered in Clearwater, Florida and currently employs 272 full-time employees. The firm operates through two segments: Advanced Energy and original equipment manufacturer (OEM). Its Advanced Energy product portfolio consists of its Helium Plasma Technology that is marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. These product lines consist of a multifunction generator, a handpiece, and a supply of helium gas. Its primary focus is on the cosmetic surgery market, where Renuvion offers plastic surgeons, fascial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. The firm designs, develops, and manufactures electrosurgical equipment by producing generators and related accessories for medical device manufacturers through original equipment manufacturing (OEM) agreements, as well as start-up companies with the need for its energy-based designs.
Contact
IPO
Employees
Officers
The intrinsic value of one APYX stock under the Base Case scenario is 6.02 USD.
Compared to the current market price of 1.38 USD, Apyx Medical Corp is Undervalued by 77%.